Try our Advanced Search for more refined results
Securities
-
March 25, 2026
EV Co. Investors Get Final OK Of $13.3M Deal, Atty Fees
Investors in bankrupt electric vehicle company Arrival have gotten final approval for their nearly $13.3 million deal ending claims the company touted a purportedly profitable business plan as it went public via merger with a special purpose acquisition company only to scale back its projections within a year of the merger announcement.
-
March 25, 2026
Ex-Nikola CEOs Can't Get Bankruptcy Pause For Investor Suit
Former CEOs of bankrupt electric-truck maker Nikola Corp. can't hit pause on proposed investor class action claims they face while related claims against the company are stayed amid its bankruptcy proceedings, an Arizona federal judge has determined.
-
March 25, 2026
Extreme Networks Must Face Suit Over COVID-Era Demand
A California federal judge rejected Extreme Networks' bid to dismiss a suit alleging it misled investors about its financial prospects and declining client demand during the COVID-19 pandemic, saying the investors adequately pled that the cloud network equipment company engaged in a scheme to inflate revenues through so-called channel-stuffing.
-
March 25, 2026
FINRA Constitutionality Case Belongs In 4th Circ., Judge Says
A North Carolina federal judge has thrown out a lawsuit challenging the constitutionality of the Financial Industry Regulatory Authority's in-house disciplinary process, saying the case belongs before the Fourth Circuit.
-
March 25, 2026
Warren Grills Fed's Ex-BigLaw Supervision Chief On Conflicts
Sen. Elizabeth Warren, D-Mass., on Wednesday asked former Davis Polk & Wardwell LLP veteran Randall Guynn, a recent addition to the Federal Reserve, to explain how he is dealing with potential conflicts of interest stemming from his previous role chairing the BigLaw firm's financial institutions group.
-
March 25, 2026
Paragon 28 Beats Investor Suit Over Inventory Accounting
A Colorado federal judge has permanently tossed a proposed class action against Paragon 28 Inc., which makes products for foot and ankle surgery, and its executives claiming that they misrepresented the company's inventory levels and key financial metrics, finding that the suit fails to plausibly plead that the defendants knowingly made the misleading statements.
-
March 25, 2026
Binance Will Challenge Singapore Arbitration Bid Denial
Binance will appeal a New York federal judge's ruling last month refusing to force users of the platform who accuse the crypto exchange of improperly selling securities to arbitrate their claims before the Singapore International Arbitration Centre.
-
March 25, 2026
Serta Lenders End Trial Over 'Uptier' Ahead Of Summer Ruling
Lenders to Serta Simmons Bedding presented closing arguments in Texas bankruptcy court Wednesday in a trial over damages that investors excluded from the mattress maker's 2020 "uptier" deal say they should be awarded, an issue which the presiding judge expects to decide on in the next few months.
-
March 25, 2026
FSOC Seeks To Rein In Too-Big-To-Fail Labels In Latest Pivot
Federal regulators moved Wednesday to curb their authority to subject large asset managers, insurers and other nonbank firms to heightened, bank-like supervision, proposing guidelines that would reinstitute tougher standards for these too-big-to-fail designations.
-
March 25, 2026
After Overhaul Nixed, FTC, DOJ Mull New Merger Rulemaking
The Federal Trade Commission and the U.S. Department of Justice are not giving up on attempting to overhaul the "insufficient" half-century-old merger notification form after its replacement was just struck down by a Texas federal judge, with the agencies now seeking public comment as they mull "a new rulemaking process."
-
March 25, 2026
Judge Trims SEC Fraud Case Over Cancer Drug Claims
A Massachusetts federal judge greenlighted U.S. Securities and Exchange Commission claims against two of three former pharmaceutical executives accused of concealing from investors the U.S. Food and Drug Administration's "harsh critiques" about a cancer drug.
-
March 25, 2026
Insurer Need Not Cover Parkinson's Drug Antitrust Dispute
An insurer does not owe coverage in an antitrust suit accusing a pharmaceutical company of suppressing generic versions of the Parkinson's treatment Apokyn, a Maryland federal judge ruled, finding the dispute does not involve "securities claims" covered under the insurer's policy.
-
March 25, 2026
Del. Chancellor Pauses Tesla Suit As Musk Cites LinkedIn Post
The Delaware Chancery Court has paused a high-profile Tesla stockholder case following a recusal bid from Elon Musk and Tesla Inc. after a judge's LinkedIn account appeared to react to a post celebrating a recent California jury verdict against Musk, including language praising efforts to stand up to "the richest man in the world."
-
March 24, 2026
Charlie Javice Can't Get Retrial Based On Clerk Conflicts
A New York federal judge Tuesday shot down a retrial bid from Charlie Javice, who was convicted of conning JPMorgan Chase & Co. into buying her financial aid startup Frank, rejecting her argument that there was a conflict of interest because clerks who worked on the trial accepted jobs with the bank's firm.
-
March 24, 2026
NY Regulator's Fintech Unit Chief Is Ex-BigLaw, CFPB Analyst
New York's financial services regulator announced Tuesday it has promoted one of its own to permanently head up its division responsible for licensing crypto firms and regulating fintech, a job formerly held by the agency's current acting Superintendent Kaitlin Asrow.
-
March 24, 2026
Iowa Asks 5th Circ. To Ax 'Uncertain' Schwab Antitrust Deal
Iowa's attorney general Monday pressed the Fifth Circuit to reject investors' deal with The Charles Schwab Corp. in an antitrust suit over its merger with TD Ameritrade, arguing it offers only uncertain and hypothetical relief to class members while giving named plaintiffs and class counsel a "windfall."
-
March 24, 2026
Game Developer Seeks To Toss Suit Over NFT Delay
Game development studio Neon Machine Inc. urged a New York federal court to dismiss a suit brought by an investment fund specializing in virtual "real estate" over the company's alleged failure to timely deliver an unregistered NFT associated with an unreleased game, arguing the delays in developing the game do not warrant a securities fraud suit.
-
March 24, 2026
AI Tools May 'Disrobe' Meta Of Section 230 Shield, Judge Says
A California federal judge trimmed Tuesday a proposed class action alleging Meta Platforms Inc. knowingly participated in a Chinese pump-and-dump scheme advertised on social media, but found there's a factual dispute over whether Meta's AI tools materially contributed to the "facially ridiculous" ads.
-
March 24, 2026
SEC Casts Doubt On Egan-Jones' Reentry Into Bond Ratings
Egan-Jones Ratings Co. has found itself back under the U.S. Securities and Exchange Commission's microscope 13 years after the agency pulled its permission to rate government bonds, with the SEC recently expressing concern that the company isn't ready to reenter the space.
-
March 24, 2026
FINRA CEO Highlights New Clearinghouse For Cyber Threats
Robert Cook, CEO of the Financial Industry Regulatory Authority, said Tuesday that it will soon be rolling out a clearinghouse for firms to report cybersecurity threats and to promote information sharing across the industry.
-
March 24, 2026
2nd Circ. Won't Recharge Solar Panel Co. Investor Suit
The Second Circuit won't revive a proposed investor class action alleging solar panel infrastructure company Array Technologies failed to convey the impact of certain heightened costs stemming from the COVID-19 pandemic.
-
March 24, 2026
Agenus Escapes Investor Fraud Suit Over Cancer Drug
A Massachusetts federal judge on Tuesday tossed securities fraud claims against Agenus Inc., saying the biotech company did not conceal the risk that a colorectal cancer therapy it was developing might face roadblocks.
-
March 24, 2026
Drug Co. Atara Hit With Investor Suit Over FDA Denial
Drug company Atara Biotherapeutics Inc. has been hit with a proposed class action accusing it of harming investors by not disclosing certain manufacturing problems and research study deficiencies that made it unlikely the U.S. Food and Drug Administration would approve its new drug application.
-
March 24, 2026
11th Circ. 'Looking For Boundaries' In Ponzi Probe Appeal
The Eleventh Circuit appeared conflicted Tuesday over a former CEO's claims that he was wrongly hit with more than $800,000 in penalties after a civil securities complaint into an alleged Ponzi scheme, weighing whether he was properly dinged for three violations over one enterprise.
-
March 24, 2026
Delaware Court Tosses Allied Gaming Suit, Awards $5.9M Fees
The Delaware Chancery Court on Tuesday dismissed a stockholder challenge to a disputed share issuance at Allied Gaming & Entertainment Inc. as moot, while ordering the company to pay nearly $5.94 million in attorney fees and expenses after finding that the litigation prompted the company to reverse course.
Expert Analysis
-
Easing Equity Research Firewall Shows SEC Open To Updates
The U.S. Securities and Exchange Commission’s recent agreement to modify a decades-old settlement meant to limit investment bankers’ influence over research analysts within major broker-dealer firms reflects a shift toward a commission that recognizes how rules can be modernized to lighten compliance burdens without eliminating core safeguards, say attorneys at Ropes & Gray.
-
Series
Calif. Banking Brief: All The Notable Legal Updates In Q4
The regulatory and litigation developments for California financial institutions in the fourth quarter of 2025 were incremental but consequential, with the Department of Financial Protection & Innovation relying on public enforcement actions to articulate expectations, and lawmakers and privacy regulators playing a role as well, says Stephen Britt at Stinson.
-
Series
Fly-Fishing Makes Me A Better Lawyer
Much like skilled attorneys, the best anglers prize preparation, presentation and patience while respecting their adversaries — both human and trout, says Rob Braverman at Braverman Greenspun.
-
4 Ways GCs Can Manage Growing Service Of Process Volume
As automation and arbitration increase the volume of legal filings, in-house counsel must build scalable service of process systems that strengthen corporate governance and manage risk in real time, says Paul Mathews at Corporation Service Co.
-
Series
NY Banking Brief: All The Notable Legal Updates In Q4
In the fourth quarter of last year, New York state enacted several developments that affect financial services regulation and business, cementing upcoming compliance obligations including cybersecurity best practices and retail stores' cash management, says Chris Bonner at Barclay Damon.
-
SDNY Atty Signals Return To Private Fund Valuation Scrutiny
Recent remarks by the U.S. Attorney for the Southern District of New York — hinting that regulators are renewing their focus on private fund advisers who overvalue portfolio assets to drive up investor fees — should prompt firms to review their valuation methodologies and address potential conflicts of interest now, say attorneys at Debevoise.
-
IP Appellate Decisions Show 4 Shifts In 2025
In 2025, intellectual property decisions issued by the Ninth, D.C., and Federal Circuits trended toward tightening doctrinal boundaries, whether to account for technological developments in existing legal regimes, or to refine areas with some ambiguity, says Nate Sabri at Perkins Coie.
-
Series
The Law Firm Merger Diaries: Forming Measurable Ties
Relationship-building should begin as early as possible in a law firm merger, as intentional pathways to bringing people together drive collaboration, positive client response, engagements and growth, says Amie Colby at Troutman.
-
Del. Dispatch: What Tesla Decision Means For Exec Comp
The recent Delaware Supreme Court decision granting Tesla CEO Elon Musk his full pay, now valued at $139 billion, following a yearslong battle appears to reject the view that supersized compensation may be inherently unfair to a corporation and its shareholders, say attorneys at Fried Frank.
-
Wis. Sanctions Order May Shake Up Securities Class Actions
A Wisconsin federal court’s recent decision to impose sanctions on a plaintiffs law firm for filing a frivolous Private Securities Litigation Reform Act complaint in Toft v. Harbor Diversified may cause both plaintiffs and defendants law firms to reconsider certain customary practices in securities class actions, says Jonathan Richman at Brown Rudnick.
-
5 E-Discovery Predictions For 2026 And Beyond
2026 will likely be shaped by issues ranging from artificial intelligence regulatory turbulence to potential evidence rule changes, and e-discovery professionals will need to understand how to effectively guide the responsible and defensible adoption of emerging tools, while also ensuring effective safeguards, say attorneys at Littler.
-
Where States Jumped In When SEC Stepped Back In 2025
The state regulators that picked up the slack when the U.S. Securities and Exchange Commission scaled back enforcement last year should not be underestimated as they continue to aggressively police areas where the SEC has lost interest and probe industries where SEC leadership has actively declined to intervene, say attorneys at Morgan Lewis.
-
What's On Deck In Tribal Nations' Prediction Markets Litigation
Native American tribes' response to the expansion of sports-based prediction markets enters a decisive phase this year, with appellate courts positioned to address whether federal commodities law permits nationwide offering of sports-based event contracts free from state and tribal gaming regulation, say attorneys at Holland & Knight.
-
Reviewing Historical And Recent NYDFS Blockchain Guidance
Excerpt from Practical Guidance
An industry letter released in the fall by the New York State Department of Financial Services, together with guidance issued over the past decade, signals a heightened regulatory expectation for covered institutions regarding the use of blockchain analytics and requires review, says Nicole De Santis at Nomadis Consulting.
-
SEC Virtu Deal Previews Risks Of Nonpublic Info In AI Models
The U.S. Securities and Exchange Commission’s recent settlement with Virtu Financial Inc. over alleged failures to safeguard customer data raises broader questions about how traditional enforcement frameworks may apply when material nonpublic information is embedded into artificial intelligence trading systems, says Braeden Anderson at Gesmer Updegrove.